Clinical Quality Oversight Conference

June 6-8, 2022  |  Philadelphia, PA + Virtual

Clinical quality oversight has been significantly impacted by the forced change and rapid technology adoption catalyzed by the pandemic, as well as new regulations driving quality cultures and quality by design. This is a critical time in clinical research and an opportunity to adopt risk-based oversight approaches that ensure quality and mitigate risk. This interactive gathering of senior-level clinical quality, compliance and operations professionals offers an opportunity to engage in-person with like-minded peers often struggling with the same challenges. Learn together through presentations, panels, roundtables, and instructional workshops and be part of Momentum’s clinical quality community. Learn more ›

Use discount code WCGA15 to save 15%

Join Avoca for the following sessions:

Tuesday, June 7, 2022

11:15am ET – REGULATORY UPDATE: NEW SPONSOR AND CRO INSPECTION PROCEDURES

Review Recent “BIMO” Updates and What to Expect for Upcoming Inspections

• • Discuss increased focus on outsourced services that are critical to quality
  • Understand how to adequately showcase oversight during COVID
  • Evaluate changes to monitoring procedures and activities
  • Expectations for risk management plans and demonstrating safety oversight
  • Describe increased focus on clinical data integrity

Presenter: Michelle Webb, Vice President, Avoca Quality Consortium

3:00pm ET – EXPERT PANEL: COLLABORATE TO OPTIMIZE QUALITY

Evaluate How Sponsors Can Best Work with Partners to Optimize Clinical Quality

• • Discuss strategies for optimizing a culture of quality across all stakeholders
  • Strategize on building relationships with partners who have common goals/culture
  • Examine different oversight approaches and what works best to optimize quality
  • Identify best practices for oversight during and beyond the pandemic

Moderator: Cristin MacDonald, PhD, Vice President, Client Delivery, WCG Avoca

Panelists:

• • Maryann Livolsi, Senior Director, GCP Quality Assurance, Bill and Melinda Gates Medical Research Institute
  • Michele Weitz, Executive Director, Clinical Standards and Innovation, Clovis Oncology

Hosted by:

Event Sponsor:

Consortium Partner: